Deathfrom venous thromboembolism occurs in the perioperative period at a rate varying between O. J % and 7.0%. The risk factors and methods of prophylaxis are reviewed and current recommendations presented.
pulmonary emboli in the two groups, the trial essentially failed to show that low-dose heparin reduced mortality in the group as a whole, mainly because pulmonary emboli caused only a small percentage of all the postoperative deaths.
Recent extensive reviews ll -13 however, together with the publication of the National Institutes of Health Consensus Development Conference report,14 provide strong support for the widespread use of prophylactic measures to guard against deep vein thrombosis in those patients who fall into moderate to high risk categories. While prophylaxis against potentially fatal pulmonary emboli is the main goal, prophylaxis to prevent the late sequelae of extensive deep vein thrombosis -swelling of the legs, varicose veins, ulceration and other trophic changes -are also important considerations.
Venous thrombosis has a multifactorial aetiology and many risk factors have been identified ( Table 1) . Surgery is only one of these. These risk factors have been classified into a useful schema by Hull et al. 11 which incorporates the type and duration of surgery with the expected risk of a thromboembolic event ( Table 2) . Prophylaxis can be approached using either pharmacological, mechanical, or specific anaesthetic techniques, alone or in combination.
PHARMACOLOGICAL METHODS Heparin is the most widely used drug in the prophylaxis of DVT. Heparin activates plasma antithrombin III which, in turn, blocks the enzymic activity of the activated clotting factors, primarily Xa but also lIa, IXa, XIa, Xlla and plasmin.
Heparin as a low-dose subcutaneous injection of 5000 units is usually commenced two hours prior to surgery and continued until the patient is fully mobile or discharged. There appears to be no difference in efficacy with either the 8-hour regime or the more convenient 12-hour regimeY Either the calcium or sodium salt can be used. 16 Major haemorrhagic side-effects from low-dose unfractionated heparin are small as assessed by intraand postoperative blood loss and transfusion requirements. IO Ultra low-dose heparin requires a continuous intravenous infusion of heparin at a dose of 1.0 unit/kg/hr for five daysY The mechanisms of action of ultra low-dose heparin are thought to involve effects on lipoprotein lipase activity, platelet adhesiveness and the release of endogenous glycosaminoglycans.
Low molecular weight fractionated heparin
has recently been undergoing trials. 20 . 22 Heparin is a mixture of polysaccaharide molecules that vary in molecular weight between 2000 and 40,000. This mixture can be fractionated to give a preparation of average molecular weight of 4000-6000. This substance which potentiates the inhibition of Xa, with less prolongation of the APTT than unfractionated heparin, has been experimentally shown to have more antithrombotic potency with less risk of haemorrhagic complications. Furthermore, because of its prolonged half-life, it need only be administered as a single daily dose. 23 In a prospective double-blind trial, Bergquist et al. 22 showed that a single dose of 5000 units of low molecular weight heparin gave the same protection as 5000 units b.d. of conventional low-dose heparin. More work is yet required to clarify the optimal dose and time of administration prior to surgery.
Oral anticoagulants are widely used in the late treatment of pulmonary embolism and deep vein thrombosis and as prophylaxis in valvular heart disease. These drugs inhibit the synthesis of the vitamin K-dependent coagulation factors. Warfarin is the most widely used agent. Many studies have shown its efficacy in high risk patients. 2 4-26 Ideally the drug should be administered before the risk of thromboembolism develops which is often not possible in the acute surgical patient. However, a first dose during surgery or the early postoperative period may prevent the extension of venous thrombosis. 11 The degree of anticoagulation required has been a subject of controversy as the result of different thromboplastin preparations being used to determine the prothrombin time. The current recommendation 14 in high-risk patients is to prolong the prothrombin time to an International Normalised Ratio (INR) of 2.0 to 3.0 (1.2 to 1.5 times the control) using rabbit brain thromboplastin. It has been estimated that fatal haemorrhage may occur in up to 0.3% of patients receiving warfarin prophylaxis;27 this, together with the increased transfusion requirements and need for careful laboratory monitoring of the INR are drawbacks to the more widespread use of oral anticoagulants, despite their evident efficacy in high-risk patients.
A two-stage warfarin regime has been recommended in an attempt to decrease perioperative blood loss. For elective major orthopaedic surgery warfarin was administered 10 to 14 days preoperatively and the prothrombin time regulated to between 1.5 and 3 seconds longer than the control values. Immediately following surgery the dose was increased to prolong the prothrombin time to 1.5 times the control. This trial 28 showed a clinical and statistically significant advantage for the warfarin group and there was no difference between the groups with regard to postoperative bleeding.
Warfarin has also been given as a low fixed dose of 1 mg daily for up to three weeks preoperatively continuing throughout the patient's hospital stay. A randomised trial 29 showed a statistically significant lower incidence of DVT in the study group compared with a control. This promising simple regime which avoids the requirement for laboratory control needs confirming with larger studies.
Intravenous dextran is a glucose polymer available in solutions with mean molecular weights of either 40,000 or 70,000. These solutions cause a relative haemodilution, a decrease in blood viscosity, an alteration in platelet function and interference with the polymerisation of fibrin. 13 Dextran 40,000 and 70,000 are equally effective in preventing deep vein thrombosis in high-risk patients. 12 It is recommended that 500 ml be given intraoperatively, then daily for three to five days. Patients mobilised immediately postoperatively may not need the postoperative treatment. Fluid overload, maintenance of intravenous access, risk of anaphylactoid reactions and cost have been raised as objections to the use of dextran solutions.
The risk of dextran-induced anaphylactoid reactions varies between 0.008% and 0.69% per unit infused. Pau1l 31 recently conducted a prospective study of women in an obstetric and gynaecological hospital and reported an incidence of severe reactions (Grade III + IV)32 of 1 in 821 patients treated. These severe reactions can be virtually abolished by the use of hapten dextran prophylaxis. 33 Twenty millilitres of monovalent hapten dextran (15% dextran 1, molecular weight 1000) is given IV, two to three minutes before starting the infusion of dextran 40,000 or 70,000. 30 ,34.35 Dihydroergotamine and its metabolites cause an increase in venous smooth muscle tone thereby reducing peripheral venous pooling and an increase in femoral vein blood flow velocity. 36 It is usually used in combination with heparin. A 1986 review of all published trials comparing conventional low-dose heparin and a heparin dihydroergotamine combination showed an approximate 50% risk reduction in the dihydroergotamine combination groups across a wide range of surgical procedures. 37 Dihydroergotamine is unfortunately not without risk. Several cases of prolonged arterial spasm 38 ,39 have been reported, some leading to gangrene. 40
MECHANICAL METHODS
Intermittent pneumatic leg compression attempts to decrease venostasis by increasing venous return through the deep veins of the lower limb to the central circulation and it has also been shown to have a beneficial effect on systemic fibrinolytic activity. [41] [42] [43] Several different pneumatic devices are available; those providing sequential or wavelike compression along the limb may be more effective than those providing only calf compression. 44 ,45 The optimal inflation compression cycle is a rapid rise to about 40 mmHg pressure with a slower deflation and a cycle time of between one and two minutes. If immobilisation in the postoperative period is likely to be prolonged, this technique can be continued during that time. The major advantage of intermittent pneumatic compression is that it has no deleterious effects on haemostasis and may be used in Anaesthesia and Intensive Care, Vol. 17. No. 4. November, 1989 ophthalmic and neurosurgical patients. 46 ,47 Some reports claimed the technique to be ineffective in patients with malignancy, but more recently patients with gynaecological malignancy have been significantly protected 48 and there are several studies demonstrating its effect in non-cancer surgery. 49-5 1
Electrical calf stimulation with an optimal stimulation rate of once every four seconds was recommended as a method of prophlaxis in the early '70s and shown to be effective in moderate risk patients. 52 ,53 There are, however, no recent reports confirming this. Likewise there are no studies showing femoral vein blood flow velocities during stimulation as there are with intermittent pneumatic compression. In a randomised study of three groups, the incidence of 125-I-fibrinogen detected deep venous thrombosis in an electrical calf stimulation group was 18%, in a low-dose heparin group 9%, and in an intermittent sequential compression combined with thromboembolism stockings 4%.54 So the current place of electrical calf stimulation in the prophylaxis of deep venous thrombosis may be open to question.
REGIONAL ANAESTHETIC TECHNIQUES
Lumbar epidural and spinal anaesthesia for open surgery on the prostate,55 and elective 56 and emergency hip surgery57 have been shown to decrease the frequency of deep venous thrombosis when compared to patients . receiving general anaesthesia for similar types of surgery. The mechanisms whereby regional anaesthesia may decrease the incidence of perioperative deep venous thrombosis include the increase in blood flow in the lower limbs due to a decrease in vascular resistance,58.59 a decrease in blood viscosity from haemodilution, a change in red cell deformability60 together with an effect on fibrinolysis and platelet aggregationY-63 In the postoperative period lumbar epidural analgesia may be continued with either weaker anaesthetic solutions or the substitution of epidural narcotics, thus allowing pain-free earlier mobilisation.
Other techniques are available to reduce the incidence of deep venous thrombosis. Early ambulation with active and passive leg exercises in the postoperative period may be of benefit in low-risk groups.13 Plain elastic stockings have been shown to be ineffective,64 while graded elastic stockings in the low-risk general surgical population may be beneficial. l3 ,65 Despite the apparently benign nature of compression stockings, too tight stockings can cause morbidity, especially in patients with peripheral vascular disease. 66, 67 Aspirin administered preoperatively for its anti platelet effect has produced conflicting results, the only groups to show benefit being those involving male orthopaedic patients. 68 An interesting accompaniment of intermittent compression of the arm is that systemic fibrinolytic activity is increased and Knight 69 has shown an effect on deep venous thrombosis in the legs. This may be of significance with the widespread use of automatic non-invasive blood pressure machines.
Trials involving combinations of methods are limited. Those combining dihydroergotamine with heparin have already been discussed. 37 ,70,71 Intermittent pneumatic leg compression combined with intravenous dextran 72 and graded elastic stockings combined with intermittent pneumatic compression 54 have all shown promising results.
The role of the contraceptive pill (OCP) in the development of perioperative deep venous thrombosis is still being questioned. An editorial in 1985 73 reviewed the subject and recommended that women taking an oestrogen containing OCP who were to undergo major elective surgery, should discontinue the OCP four weeks preoperatively (while receiving adequate alternative contraceptive care). The OCP could be recommenced at the first menses at least two weeks following the procedure. If discontinuation of the OCP had not occurred -for example after trauma or by oversight, prophylactic low-dose heparin should be considered. It has recently been suggested that the risk of thromboembolism in young, slim, healthy women on the OCP, undergoing intraabdominal surgery, may be very low. 74 The consensus of opinion however, appears to be that the 1985 recommendation should stand until the true incidence is defined. 75 -78 These recommendations were not intended to apply to minor surgery of short duration followed by early mobilisation or to women taking an oestrogen-free OCP. A recent survey of anaesthetists in the North Western Regional Health Authority in the U.K. (unpublished) suggested that this advice was not closely followed. Eighty out of 200 respondents would have declined to anaesthetise a woman for elective major surgery if she were taking the OCP while the remainder would have done so but used some form of prophylaxis such as subcutaneous heparin.
Once the risk factors have been identified and corrected where possible, the appropriate anaesthetic technique and suitable method of prophylaxis can be chosen. The National Institutes of Health Consensus Conference had made absolute recommendations for only limited groups of patients, i.e. those at moderate risk, those undergoing neurosurgical, major knee or urological procedures and elective and emergency hip surgery. 14 These recommendations have been combined with those of Hull et al. 11 in Table 3 . Discussion between anaesthetist and surgeon should take place and consideration be given for the institution of routine prophylaxis regimes. That there 1S a reluctance amongst surgeons to use prophylaxis is well demonstrated. 79 . 80 The anaesthetist can play an active role in prophylaxis, instituting pneumatic compression, administering dextran and some of the heparin regimes and choosing a regional anaesthetic technique where practicable. There may even be a place in prescribing a heparin regime with the premedication.
There is no doubt that effective methods to reduce the incidence of deep venous thrombosis and fatal pulmonary embolus are available. All that remains is for their more widespread acceptance into routine clinical practice.
